Treatment of canine multicentric lymphoma through vascular access port vs. peripheral venous catheter

Detalhes bibliográficos
Autor(a) principal: Barni, Brunna de Souza
Data de Publicação: 2020
Outros Autores: Herrera Becerra, José Ricardo, Vidor, Silvana Bellini, Oliveira, Mariana Pires de, Vieira, Luciane Cristina, Gnoatto, Calvin Braga, Valle, Stella de Faria, Gomes, Cristiano, Gianotti, Giordano Cabral, Contesini, Emerson Antônio
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/211842
Resumo: Background: Vascular access port (VAP) was developed for the administration of chemotherapeutic agents, minimizing local drug reactions and complications associated with migration of peripheral venous catheter (PVC) in humans. The device is widely used in human oncology and has gained importance in veterinary oncology, especially in long treatment regimens, as in the case of canine lymphoma. VAP favors therapy and the animals life quality. The aim of this study was to describe the use of VAP in dogs, comparing to PVC access, during canine lymphoma chemotherapeutic treatment. Materials, Methods & Results: Eleven dogs with multicentric lymphoma which required chemotherapy were selected for the study. The dogs were randomly allocated to two groups with five and six animals, and each group received the chemotherapy protocol through the PVC (n= 5) or VAP (n= 6). For the sake of standardization, assessments were made whenever the dogs received vincristine sulfate, despite the use of the infusion system in all sessions of the Madison- Wisconsin protocol. A VAP was implanted into the right external jugular vein of six dogs under inhalational anesthesia, using the Seldinger technique. Systolic blood pressure (SBP) levels and handling time during chemotherapy sessions were compared in both groups in three time periods during the procedures: 10 min after arrival to each chemotherapy (P1); immediately after placement of the PVC or puncture of the VAP reservoir (P2); and at the end of chemotherapy (P3). The arithmetic mean of five consecutive assessments was used in each time period. In the chemotherapy sessions, the mean of SBP variation decreased statistically significant in the VAP group compared to PVC group. SBP decreased from P1 to P2 and from P1 to P3 in all sessions (S1, S2, and S3) in the VAP group, and increased in the PVC group. The handling time of VAP group was 110.6 ± 8.4 s, compared to 219.2 ± 24.7 s (mean ± standard error) in the PVC group, showing statisti¬cally significant difference (P < 0.001). VAP surgical implantation time averaged 37 min, decreasing gradually from the first (55 min) to the last patient (21 min). Discussion: SBP levels suggest that the VAP group was calmer from the beginning to the end of the sessions, showed lower SBP levels, and required shorter handling time than did the PVC group. Blood pressure is one of the most objec¬tive ways to assess welfare or stress in dogs. When dog feels threatened or scared, its body automatically enters a state of emergency and, among several changes, blood pressure increases. VAP surgical implantation in dogs have easy learning, as previously described, proven by implantation time progressive reduction. The Seldinger technique is the method of choice for catheter implantation in humans. Dissection of the jugular vein is an alternative, however, the technique with a single incision and venipuncture is less invasive than its modifications. The jugular vein was used because is the site of choice for central accesses in veterinary practice, with a shorter path to the right atrium and smaller rates of catheter mis¬placement, reducing the risk of pneumothorax, venous thrombosis, and pinch-off syndrome. VAP surgical implantation in dogs have easy learning, proven by the implantation time progressive reduction. The study confirmed that VAP promoted animal welfare, shortened chemotherapy sessions, and caused less discomfort to dogs treated for multicentric lymphoma, as indicated by the reduction in SBP, when compared to the PVC group.
id UFRGS-2_5a6e6388bf927c76017d8fcbf7b50647
oai_identifier_str oai:www.lume.ufrgs.br:10183/211842
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Barni, Brunna de SouzaHerrera Becerra, José RicardoVidor, Silvana BelliniOliveira, Mariana Pires deVieira, Luciane CristinaGnoatto, Calvin BragaValle, Stella de FariaGomes, CristianoGianotti, Giordano CabralContesini, Emerson Antônio2020-07-11T03:53:33Z20201678-0345http://hdl.handle.net/10183/211842001115649Background: Vascular access port (VAP) was developed for the administration of chemotherapeutic agents, minimizing local drug reactions and complications associated with migration of peripheral venous catheter (PVC) in humans. The device is widely used in human oncology and has gained importance in veterinary oncology, especially in long treatment regimens, as in the case of canine lymphoma. VAP favors therapy and the animals life quality. The aim of this study was to describe the use of VAP in dogs, comparing to PVC access, during canine lymphoma chemotherapeutic treatment. Materials, Methods & Results: Eleven dogs with multicentric lymphoma which required chemotherapy were selected for the study. The dogs were randomly allocated to two groups with five and six animals, and each group received the chemotherapy protocol through the PVC (n= 5) or VAP (n= 6). For the sake of standardization, assessments were made whenever the dogs received vincristine sulfate, despite the use of the infusion system in all sessions of the Madison- Wisconsin protocol. A VAP was implanted into the right external jugular vein of six dogs under inhalational anesthesia, using the Seldinger technique. Systolic blood pressure (SBP) levels and handling time during chemotherapy sessions were compared in both groups in three time periods during the procedures: 10 min after arrival to each chemotherapy (P1); immediately after placement of the PVC or puncture of the VAP reservoir (P2); and at the end of chemotherapy (P3). The arithmetic mean of five consecutive assessments was used in each time period. In the chemotherapy sessions, the mean of SBP variation decreased statistically significant in the VAP group compared to PVC group. SBP decreased from P1 to P2 and from P1 to P3 in all sessions (S1, S2, and S3) in the VAP group, and increased in the PVC group. The handling time of VAP group was 110.6 ± 8.4 s, compared to 219.2 ± 24.7 s (mean ± standard error) in the PVC group, showing statisti¬cally significant difference (P < 0.001). VAP surgical implantation time averaged 37 min, decreasing gradually from the first (55 min) to the last patient (21 min). Discussion: SBP levels suggest that the VAP group was calmer from the beginning to the end of the sessions, showed lower SBP levels, and required shorter handling time than did the PVC group. Blood pressure is one of the most objec¬tive ways to assess welfare or stress in dogs. When dog feels threatened or scared, its body automatically enters a state of emergency and, among several changes, blood pressure increases. VAP surgical implantation in dogs have easy learning, as previously described, proven by implantation time progressive reduction. The Seldinger technique is the method of choice for catheter implantation in humans. Dissection of the jugular vein is an alternative, however, the technique with a single incision and venipuncture is less invasive than its modifications. The jugular vein was used because is the site of choice for central accesses in veterinary practice, with a shorter path to the right atrium and smaller rates of catheter mis¬placement, reducing the risk of pneumothorax, venous thrombosis, and pinch-off syndrome. VAP surgical implantation in dogs have easy learning, proven by the implantation time progressive reduction. The study confirmed that VAP promoted animal welfare, shortened chemotherapy sessions, and caused less discomfort to dogs treated for multicentric lymphoma, as indicated by the reduction in SBP, when compared to the PVC group.application/pdfengActa scientiae veterinariae. Porto Alegre, RS. Vol. 48 (2020), Pub. 1738, 8 p.Dispositivos de acesso vascularCateterismo periféricoQuimioterapiaLinfomaCãesAntineoplastic therapyCanineOncologyPort-a-cathTreatment of canine multicentric lymphoma through vascular access port vs. peripheral venous catheterinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001115649.pdf.txt001115649.pdf.txtExtracted Texttext/plain31537http://www.lume.ufrgs.br/bitstream/10183/211842/2/001115649.pdf.txt5639e6ee37c33e1f71c338be7040497eMD52ORIGINAL001115649.pdfTexto completo (inglês)application/pdf1091862http://www.lume.ufrgs.br/bitstream/10183/211842/1/001115649.pdf7789883bd667c7156997d863dcbc7b6dMD5110183/2118422020-07-12 03:42:16.285314oai:www.lume.ufrgs.br:10183/211842Repositório InstitucionalPUBhttps://lume.ufrgs.br/oai/requestlume@ufrgs.bropendoar:2020-07-12T06:42:16Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Treatment of canine multicentric lymphoma through vascular access port vs. peripheral venous catheter
title Treatment of canine multicentric lymphoma through vascular access port vs. peripheral venous catheter
spellingShingle Treatment of canine multicentric lymphoma through vascular access port vs. peripheral venous catheter
Barni, Brunna de Souza
Dispositivos de acesso vascular
Cateterismo periférico
Quimioterapia
Linfoma
Cães
Antineoplastic therapy
Canine
Oncology
Port-a-cath
title_short Treatment of canine multicentric lymphoma through vascular access port vs. peripheral venous catheter
title_full Treatment of canine multicentric lymphoma through vascular access port vs. peripheral venous catheter
title_fullStr Treatment of canine multicentric lymphoma through vascular access port vs. peripheral venous catheter
title_full_unstemmed Treatment of canine multicentric lymphoma through vascular access port vs. peripheral venous catheter
title_sort Treatment of canine multicentric lymphoma through vascular access port vs. peripheral venous catheter
author Barni, Brunna de Souza
author_facet Barni, Brunna de Souza
Herrera Becerra, José Ricardo
Vidor, Silvana Bellini
Oliveira, Mariana Pires de
Vieira, Luciane Cristina
Gnoatto, Calvin Braga
Valle, Stella de Faria
Gomes, Cristiano
Gianotti, Giordano Cabral
Contesini, Emerson Antônio
author_role author
author2 Herrera Becerra, José Ricardo
Vidor, Silvana Bellini
Oliveira, Mariana Pires de
Vieira, Luciane Cristina
Gnoatto, Calvin Braga
Valle, Stella de Faria
Gomes, Cristiano
Gianotti, Giordano Cabral
Contesini, Emerson Antônio
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Barni, Brunna de Souza
Herrera Becerra, José Ricardo
Vidor, Silvana Bellini
Oliveira, Mariana Pires de
Vieira, Luciane Cristina
Gnoatto, Calvin Braga
Valle, Stella de Faria
Gomes, Cristiano
Gianotti, Giordano Cabral
Contesini, Emerson Antônio
dc.subject.por.fl_str_mv Dispositivos de acesso vascular
Cateterismo periférico
Quimioterapia
Linfoma
Cães
topic Dispositivos de acesso vascular
Cateterismo periférico
Quimioterapia
Linfoma
Cães
Antineoplastic therapy
Canine
Oncology
Port-a-cath
dc.subject.eng.fl_str_mv Antineoplastic therapy
Canine
Oncology
Port-a-cath
description Background: Vascular access port (VAP) was developed for the administration of chemotherapeutic agents, minimizing local drug reactions and complications associated with migration of peripheral venous catheter (PVC) in humans. The device is widely used in human oncology and has gained importance in veterinary oncology, especially in long treatment regimens, as in the case of canine lymphoma. VAP favors therapy and the animals life quality. The aim of this study was to describe the use of VAP in dogs, comparing to PVC access, during canine lymphoma chemotherapeutic treatment. Materials, Methods & Results: Eleven dogs with multicentric lymphoma which required chemotherapy were selected for the study. The dogs were randomly allocated to two groups with five and six animals, and each group received the chemotherapy protocol through the PVC (n= 5) or VAP (n= 6). For the sake of standardization, assessments were made whenever the dogs received vincristine sulfate, despite the use of the infusion system in all sessions of the Madison- Wisconsin protocol. A VAP was implanted into the right external jugular vein of six dogs under inhalational anesthesia, using the Seldinger technique. Systolic blood pressure (SBP) levels and handling time during chemotherapy sessions were compared in both groups in three time periods during the procedures: 10 min after arrival to each chemotherapy (P1); immediately after placement of the PVC or puncture of the VAP reservoir (P2); and at the end of chemotherapy (P3). The arithmetic mean of five consecutive assessments was used in each time period. In the chemotherapy sessions, the mean of SBP variation decreased statistically significant in the VAP group compared to PVC group. SBP decreased from P1 to P2 and from P1 to P3 in all sessions (S1, S2, and S3) in the VAP group, and increased in the PVC group. The handling time of VAP group was 110.6 ± 8.4 s, compared to 219.2 ± 24.7 s (mean ± standard error) in the PVC group, showing statisti¬cally significant difference (P < 0.001). VAP surgical implantation time averaged 37 min, decreasing gradually from the first (55 min) to the last patient (21 min). Discussion: SBP levels suggest that the VAP group was calmer from the beginning to the end of the sessions, showed lower SBP levels, and required shorter handling time than did the PVC group. Blood pressure is one of the most objec¬tive ways to assess welfare or stress in dogs. When dog feels threatened or scared, its body automatically enters a state of emergency and, among several changes, blood pressure increases. VAP surgical implantation in dogs have easy learning, as previously described, proven by implantation time progressive reduction. The Seldinger technique is the method of choice for catheter implantation in humans. Dissection of the jugular vein is an alternative, however, the technique with a single incision and venipuncture is less invasive than its modifications. The jugular vein was used because is the site of choice for central accesses in veterinary practice, with a shorter path to the right atrium and smaller rates of catheter mis¬placement, reducing the risk of pneumothorax, venous thrombosis, and pinch-off syndrome. VAP surgical implantation in dogs have easy learning, proven by the implantation time progressive reduction. The study confirmed that VAP promoted animal welfare, shortened chemotherapy sessions, and caused less discomfort to dogs treated for multicentric lymphoma, as indicated by the reduction in SBP, when compared to the PVC group.
publishDate 2020
dc.date.accessioned.fl_str_mv 2020-07-11T03:53:33Z
dc.date.issued.fl_str_mv 2020
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/other
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/211842
dc.identifier.issn.pt_BR.fl_str_mv 1678-0345
dc.identifier.nrb.pt_BR.fl_str_mv 001115649
identifier_str_mv 1678-0345
001115649
url http://hdl.handle.net/10183/211842
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Acta scientiae veterinariae. Porto Alegre, RS. Vol. 48 (2020), Pub. 1738, 8 p.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/211842/2/001115649.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/211842/1/001115649.pdf
bitstream.checksum.fl_str_mv 5639e6ee37c33e1f71c338be7040497e
7789883bd667c7156997d863dcbc7b6d
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv lume@ufrgs.br
_version_ 1817725074314100736